(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three most active and biggest winners today are SmileDirectClub, Bionano Genomics, and FuboTV.

Rank Financial Asset Price Change Updated (EST)
1 SmileDirectClub (SDC) 1.61 23.46% 2022-08-11 14:50:46
2 Bionano Genomics (BNGO) 3.52 17.17% 2022-08-11 14:48:28
3 FuboTV (FUBO) 4.39 14.19% 2022-08-11 14:51:14
4 Rite Aid Corporation (RAD) 10.57 11.97% 2022-08-11 15:15:07
5 New York Times (NYT) 35.12 10.84% 2022-08-11 14:46:18
6 VerifyMe (VRME) 1.85 8.19% 2022-08-11 14:53:22
7 AMC (AMC) 25.59 8.13% 2022-08-11 14:52:28
8 Southwestern Energy (SWN) 7.49 8.08% 2022-08-11 14:48:33
9 Devon Energy (DVN) 64.59 7.56% 2022-08-11 14:57:25
10 Cenovus Energy (CVE) 18.60 7.33% 2022-08-11 14:56:48

The three most active and biggest losers today are Coinbase, XP, and Sorrento Therapeutics.

Rank Financial Asset Price Change Updated (EST)
1 Coinbase (COIN) 83.66 -11.13% 2022-08-11 14:51:58
2 XP (XP) 18.66 -9.13% 2022-08-11 14:51:48
3 Sorrento Therapeutics (SRNE) 2.49 -6.93% 2022-08-11 14:59:59
4 Revlon New (REV) 6.73 -6.79% 2022-08-11 16:23:15
5 GlaxoSmithKline (GSK) 35.74 -6.67% 2022-08-11 14:58:44
6 Exact Sciences (EXAS) 42.44 -5.95% 2022-08-11 14:57:30
7 HubSpot (HUBS) 383.76 -5.73% 2022-08-11 14:59:07
8 StoneCo (STNE) 11.27 -5.59% 2022-08-11 14:50:56
9 Upwork (UPWK) 19.00 -5.45% 2022-08-11 14:51:25
10 MicroVision (MVIS) 5.34 -5.32% 2022-08-11 14:58:14

Most Active Winners today

1. SmileDirectClub (SDC) – 23.46%

SmileDirectClub, Inc. provides a teledentistry service that allows members to receive a custom clear aligner therapy treatment both in the United States as well as internationally. It manages all aspects of the treatment process from marketing to fulfillment and treatment by a dentist. The company offers retainers, aligners and impression kits as well as whitening gels. It was established in 2014 in Nashville, Tennessee.

NASDAQ ended the session with SmileDirectClub rising 23.46% to $1.61 on Thursday, after two successive sessions in a row of gains. NASDAQ slid 0.58% to $12,779.91, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Volume

Today’s last reported volume for SmileDirectClub is 39857700 which is 1658.96% above its average volume of 2265980.

SmileDirectClub’s last close was $1.30, 82.48% below its 52-week high of $7.42.

The company’s growth estimates for the current quarter and the next is 7.1% and 56.5%, respectively.

SmileDirectClub’s Revenue

Year-on-year quarterly revenue growth declined by 31.6%, now sitting on 637.61M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

SmileDirectClub’s stock is considered to be overbought (>=80).

SmileDirectClub’s Stock Yearly Top and Bottom Value

SmileDirectClub’s stock is valued at $1.61 at 17:32 EST, way under its 52-week high of $7.42 and way higher than its 52-week low of $0.98.

SmileDirectClub’s Moving Average

SmileDirectClub’s value is way above its 50-day moving average of $1.20 and way below its 200-day moving average of $2.56.

More news about SmileDirectClub.

2. Bionano Genomics (BNGO) – 17.17%

Bionano Genomics, Inc. is a company that develops and markets life science instruments in the genomic analysis industry. Saphyr, the company’s platform for ultrasensitive and specific structural variation detection, is developed and sold by the company. This allows clinicians and researchers to quickly search for diagnostic targets and new therapeutic targets. It also streamlines the analysis of changes in the chromosomes (also known as Cytogenetics). The Saphyr system comprises an instrument, consumables for chip chips, reagents and data analysis tools. Bionano pre- and labeling kit from the company provide critical protocols and reagents for extracting and labeling high-molecular-weight DNA to use with the Saphyr. The data solutions offer hardware and software that can be used for experiment management and algorithm development. The company sells products for research purposes primarily to labs associated with universities and government research institutions. BioNano Genomics, Inc. was the company’s previous name. It changed its name in July 2018 to Bionano Genomics, Inc. Bionano Genomics, Inc. is an American company that was established in 2003. Its headquarters are in San Diego, California.

NASDAQ ended the session with Bionano Genomics jumping 17.17% to $3.52 on Thursday while NASDAQ dropped 0.58% to $12,779.91.

Volume

Today’s last reported volume for Bionano Genomics is 78242900 which is 1122.09% above its average volume of 6402310.

Bionano Genomics’s last close was $3.00, 52.9% under its 52-week high of $6.37.

Bionano Genomics’s Sales

Bionano Genomics’s sales growth is 62.9% for the ongoing quarter and 59.8% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 28.6% and a negative 28.6%, respectively.

Bionano Genomics’s Revenue

Year-on-year quarterly revenue growth grew by 57.9%, now sitting on 17.98M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Bionano Genomics’s stock is considered to be oversold (<=20).

Bionano Genomics’s Stock Yearly Top and Bottom Value

Bionano Genomics’s stock is valued at $3.52 at 17:32 EST, way under its 52-week high of $6.37 and way higher than its 52-week low of $1.16.

Bionano Genomics’s Moving Average

Bionano Genomics’s worth is way higher than its 50-day moving average of $1.56 and way above its 200-day moving average of $2.70.

More news about Bionano Genomics.

3. FuboTV (FUBO) – 14.19%

NYSE ended the session with FuboTV rising 14.19% to $4.39 on Thursday, after two sequential sessions in a row of gains. NYSE rose 0.32% to $15,602.93, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for FuboTV is 23997700 which is 97.98% above its average volume of 12120800.

FuboTV’s last close was $3.84, 89.06% below its 52-week high of $35.10.

FuboTV’s Sales

FuboTV’s sales growth is 102.2% for the present quarter and 99.7% for the next. The company’s growth estimates for the present quarter is a negative 18.6% and positive 5.9% for the next.

FuboTV’s Revenue

Year-on-year quarterly revenue growth grew by 119.9%, now sitting on 638.35M for the twelve trailing months.

FuboTV’s Stock Yearly Top and Bottom Value

FuboTV’s stock is valued at $4.39 at 17:32 EST, way below its 52-week high of $35.10 and way above its 52-week low of $2.49.

FuboTV’s Moving Average

FuboTV’s value is way above its 50-day moving average of $3.60 and way under its 200-day moving average of $13.77.

More news about FuboTV.

4. Rite Aid Corporation (RAD) – 11.97%

Rite Aid Corporation operates, via its subsidiaries in the United States, a chain retail drugstores. Two segments of the company are Retail Pharmacy and Pharmacy Services. Retail Pharmacy sells prescription medications and a variety of merchandise including personal care products, beauty and health aids, home and household goods, gift cards and seasonal merchandise. The company also runs retail clinics offering treatment for common ailments. It also provides preventative services such as screenings and medical tests, vaccinations and basic physical examinations. This segment also offers health coaching and disease management. Pharmacy Services provides services such as pharmacy benefit management and other pharmacy-related services. The segment provides prescription adjudication for PBMs and integrated mail-order services. It also offers drug benefits through Medicare Part D. The company had approximately 2400 retail pharmacies in 18 states as of 21 April 2020. Rite Aid Corporation was established in Camp Hill in Pennsylvania in 1927.

NYSE ended the session with Rite Aid Corporation rising 11.97% to $10.57 on Thursday, following the last session’s upward trend. NYSE rose 0.32% to $15,602.93, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for Rite Aid Corporation is 5958610 which is 118.83% above its average volume of 2722920.

Rite Aid Corporation’s last close was $9.44, 50.88% under its 52-week high of $19.22.

Rite Aid Corporation’s Revenue

Year-on-year quarterly revenue growth declined by 2.4%, now sitting on 24.42B for the twelve trailing months.

Rite Aid Corporation’s Stock Yearly Top and Bottom Value

Rite Aid Corporation’s stock is valued at $10.57 at 17:32 EST, way under its 52-week high of $19.22 and way above its 52-week low of $4.68.

Rite Aid Corporation’s Moving Average

Rite Aid Corporation’s worth is way above its 50-day moving average of $7.20 and way higher than its 200-day moving average of $9.58.

More news about Rite Aid Corporation.

5. New York Times (NYT) – 10.84%

NYSE ended the session with New York Times rising 10.84% to $35.12 on Thursday, after two sequential sessions in a row of gains. NYSE jumped 0.32% to $15,602.93, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for New York Times is 6478650 which is 350.5% above its average volume of 1438100.

New York Times’s last close was $31.69, 43.6% under its 52-week high of $56.19.

News about New York Times today

  • New York times stock pops 10% after valueact discloses stake. According to today’s article on MarketWatch, "Shares of New York Times have gained 8.0% over the past three months as the S&P 500 has added 7.6%.", "Shares of New York Times Co. were popping more than 10% in afternoon trading Thursday after ValueAct disclosed a stake in the media company. "

The company’s growth estimates for the ongoing quarter and the next is a negative 36.1% and a negative 8.7%, respectively.

New York Times’s Revenue

Year-on-year quarterly revenue growth grew by 16.9%, now sitting on 2.05B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

New York Times’s stock is considered to be overbought (>=80).

New York Times’s Stock Yearly Top and Bottom Value

New York Times’s stock is valued at $35.12 at 17:32 EST, way under its 52-week high of $56.19 and way higher than its 52-week low of $27.63.

New York Times’s Moving Average

New York Times’s value is higher than its 50-day moving average of $33.64 and way below its 200-day moving average of $43.33.

More news about New York Times.

6. VerifyMe (VRME) – 8.19%

VerifyMe, Inc. offers security solutions to identify and authenticate people, products, or packaging in various areas of the United States. RainbowSecure is a combination of an invisible ink and a tuned laser that allows counterfeit products to be exposed. SecureLight technology changes the color to suit various applications such as credit cards and driver’s licences. It also offers SecureLight+ technology which can authenticate products with both proprietary tuned lasers and fluorescent lighting. VeriPAS technology is also offered by the company. This technology provides brand owners with geographical information on counterfeiting. VeriPAS Smartphone Authenticator technology scans invisible RainbowSecure code labels. VerifyMe as Authentic Technology, a pre-printed dual-purpose label that includes a QR code visible for consumers scanning and an invisible serialized IR Code for inspection scanning and authentication. VerifyMe Beeper technology provides instant authentication for items such as tickets for events at a gate. VerifyMe, Inc. is a strategic partner with INX International Ink Company and Techind Engineers & Consultants – Imex. The original name of the company was LaserLock Technologies, Inc., but it changed its name in July 2015 to VerifyMe, Inc. VerifyMe, Inc. is an American company that was established in 1999. Its headquarters are in Rochester, New York.

NASDAQ ended the session with VerifyMe rising 8.19% to $1.85 on Thursday while NASDAQ dropped 0.58% to $12,779.91.

Volume

Today’s last reported volume for VerifyMe is 739507 which is 267.54% above its average volume of 201201.

VerifyMe’s last close was $1.69, 60.51% below its 52-week high of $4.28.

VerifyMe’s Sales

VerifyMe’s sales growth is 400% for the current quarter and 233.3% for the next. The company’s growth estimates for the present quarter is 38.9% and a drop 107.4% for the next.

VerifyMe’s Revenue

Year-on-year quarterly revenue growth grew by 240%, now sitting on 867k for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

VerifyMe’s stock is considered to be overbought (>=80).

VerifyMe’s Stock Yearly Top and Bottom Value

VerifyMe’s stock is valued at $1.85 at 17:32 EST, way under its 52-week high of $4.28 and way above its 52-week low of $1.47.

VerifyMe’s Moving Average

VerifyMe’s value is way under its 50-day moving average of $2.14 and way below its 200-day moving average of $2.98.

More news about VerifyMe.

7. AMC (AMC) – 8.13%

AMC Entertainment Holdings, Inc., via its subsidiaries, is involved in theatrical exhibitions. It owns or operates theatres. It operated around 1,000 theaters in America and over 11,000 worldwide screens as of March 17, 2020. It was established in 1920 in Leawood Kansas. AMC Entertainment Holdings, Inc., is a subsidiary Dalian Wanda Group Co., Ltd.

NYSE ended the session with AMC rising 8.13% to $25.59 on Thursday while NYSE jumped 0.32% to $15,602.93.

Volume

Today’s last reported volume for AMC is 75791200 which is 64.03% above its average volume of 46203100.

AMC’s last close was $23.67, 67.41% under its 52-week high of $72.62.

News about AMC today

  • AMC stock news: AMC entertainment finishes strong as meme stocks rise yet again. According to today’s article on FXStreet, "On Wednesday, shares of AMC added a further 5.41% and closed the trading session at $23.67. ", "Thanks to its recent surge, AMC is now firmly trading above both its key 50-day and 200-day moving averages."

The company’s growth estimates for the current quarter and the next is 93.6% and 96.6%, respectively.

AMC’s Revenue

Year-on-year quarterly revenue growth declined by 84.2%, now sitting on 449.2M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

AMC’s stock is considered to be overbought (>=80).

AMC’s Stock Yearly Top and Bottom Value

AMC’s stock is valued at $25.59 at 17:32 EST, way below its 52-week high of $72.62 and way higher than its 52-week low of $1.91.

AMC’s Moving Average

AMC’s value is way below its 50-day moving average of $37.41 and way below its 200-day moving average of $31.84.

Previous days news about AMC

  • AMC stock news: AMC entertainment snaps win streak as markets pull back ahead of CPI report. According to FXStreet on Wednesday, 10 August, "On Tuesday, shares of AMC dropped lower by 6.05% and closed the trading session at $22.51. "
  • Bed bath & beyond extends Monday's gains, as gamestop dips and AMC pops up 1.5%. According to MarketWatch on Tuesday, 9 August, "Other meme stocks that were swept up in Monday’s rally were mixed, with GameStop Corp. down 0.9% and AMC Entertainment Holdings Inc. up another 1.5%. "
  • AMC stock news: AMC entertainment extends meme stock rally and rises for sixth straight day. According to FXStreet on Tuesday, 9 August, "On Monday, shares of AMC added a further 7.75% and closed the trading session at $23.90. ", "While both AMC and GameStop (NYSE:GME) added to their recent rallies, it was Bed Bath and Beyond (NASDAQ:BBBY) that led the way with a staggering 39.8% gain for the day. "

More news about AMC.

8. Southwestern Energy (SWN) – 8.08%

Southwestern Energy Company is an independent energy company that specializes in exploration, development and production of natural and oil in the United States. The company operates in Exploration and Production and Marketing segments. It focuses its efforts on developing unconventional natural gas reserves in West Virginia and Pennsylvania. It had 173,994 acres of Northeast Appalachia and 287,693 acres in Southwest Appalachia as of December 31, 2019. Its proved oil and natural gas reserves, as well as NGLs and natural gas reserves, are estimated at 12,721 Bcfe. There is 929 Bcfe in undeveloped proven reserves. The company also markets natural gas, oil and NGLs. It provides services to energy companies and utilities as well as industrial buyers of natural gas. Southwestern Energy Company was established in 1929. It is located in Spring, Texas.

NYSE ended the session with Southwestern Energy rising 8.08% to $7.49 on Thursday, after four successive sessions in a row of gains. NYSE rose 0.32% to $15,602.93, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for Southwestern Energy is 28831900 which is 32.33% below its average volume of 42612000.

Southwestern Energy’s last close was $6.93, 29.79% under its 52-week high of $9.87.

Southwestern Energy’s Sales

Southwestern Energy’s sales growth is 44.2% for the present quarter and a decline by 3.4% for the next. The company’s growth estimates for the present quarter and the next is 57.9% and 29.2%, respectively.

Southwestern Energy’s Revenue

Year-on-year quarterly revenue growth grew by 174.5%, now sitting on 8.54B for the twelve trailing months.

Southwestern Energy’s Stock Yearly Top and Bottom Value

Southwestern Energy’s stock is valued at $7.49 at 17:32 EST, way under its 52-week high of $9.87 and way higher than its 52-week low of $3.81.

Southwestern Energy’s Moving Average

Southwestern Energy’s value is below its 50-day moving average of $7.65 and way higher than its 200-day moving average of $5.87.

More news about Southwestern Energy.

9. Devon Energy (DVN) – 7.56%

Devon Energy Corporation is an independent energy company that primarily engages with the development and exploration of natural gas and natural gas liquids within the United States. The company has approximately 3955 gross wells. It was established in 1971. The headquarters are located in Oklahoma City, Oklahoma.

NYSE ended the session with Devon Energy jumping 7.56% to $64.59 on Thursday while NYSE jumped 0.32% to $15,602.93.

Volume

Today’s last reported volume for Devon Energy is 12839900 which is 3.05% above its average volume of 12459900.

Devon Energy’s last close was $60.05, 24.37% under its 52-week high of $79.40.

Devon Energy’s Sales

Devon Energy’s sales growth is 100.5% for the current quarter and 40.3% for the next. The company’s growth estimates for the ongoing quarter and the next is 296.7% and 126.9%, respectively.

Devon Energy’s Revenue

Year-on-year quarterly revenue growth grew by 74%, now sitting on 14.94B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Devon Energy’s stock is considered to be oversold (<=20).

Devon Energy’s Stock Yearly Top and Bottom Value

Devon Energy’s stock is valued at $64.59 at 17:32 EST, way under its 52-week high of $79.40 and way above its 52-week low of $24.46.

Devon Energy’s Moving Average

Devon Energy’s worth is above its 50-day moving average of $61.84 and way above its 200-day moving average of $54.76.

More news about Devon Energy.

10. Cenovus Energy (CVE) – 7.33%

Cenovus Energy Inc. and its affiliates develop, produce, and market crude oil and natural gas liquids in Canada as well as natural gas products and services throughout the United States. It operates in three segments: Oil Sands, Deep Basin and Refining and Marketing. Oil Sands is responsible for developing and producing bitumen in northeast Alberta. Foster Creek, Christina Lake and Narrows Lake are just a few of its bitumen assets. There is also other early-stage projects. Clearwater, Kaybob-Edson and Elmworth-Wapiti are the main assets of the Deep Basin segment. There is also a variety of interests in natural gas processing plants. Refining and Marketing is responsible for transporting, selling, and refining crude oil to petroleum and other chemical products. The segment holds a half-ownership in Wood River, Borger and other refineries in the United States. It also owns an Alberta crude-by rail terminal. Cenovus Energy Inc. is located in Calgary, Canada. It was established in 2009.

NYSE ended the session with Cenovus Energy rising 7.33% to $18.60 on Thursday, following the last session’s upward trend. NYSE rose 0.32% to $15,602.93, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for Cenovus Energy is 9570800 which is 7.43% below its average volume of 10339600.

Cenovus Energy’s last close was $17.33, 30.43% under its 52-week high of $24.91.

Cenovus Energy’s Sales

Cenovus Energy’s sales growth is 7.2% for the present quarter and 1.4% for the next. The company’s growth estimates for the ongoing quarter and the next is 461.9% and 658.8%, respectively.

Cenovus Energy’s Revenue

Year-on-year quarterly revenue growth grew by 80.2%, now sitting on 61.79B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Cenovus Energy’s stock is considered to be oversold (<=20).

Cenovus Energy’s Stock Yearly Top and Bottom Value

Cenovus Energy’s stock is valued at $18.60 at 17:32 EST, way under its 52-week high of $24.91 and way higher than its 52-week low of $7.20.

Cenovus Energy’s Moving Average

Cenovus Energy’s value is under its 50-day moving average of $19.60 and way higher than its 200-day moving average of $16.17.

More news about Cenovus Energy.

Most Active Losers Today

1. Coinbase (COIN) – -11.13%

NASDAQ ended the session with Coinbase dropping 11.13% to $83.66 on Thursday, after two successive sessions in a row of gains. NASDAQ fell 0.58% to $12,779.91, following the last session’s upward trend on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for Coinbase is 22197200 which is 33.79% above its average volume of 16590200.

Coinbase’s last close was $94.14, 74.48% below its 52-week high of $368.90.

The company’s growth estimates for the current quarter and the next is a negative 97.7% and a negative 101.2%, respectively.

Coinbase’s Revenue

Year-on-year quarterly revenue growth grew by 327.1%, now sitting on 7.84B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Coinbase’s stock is considered to be overbought (>=80).

Coinbase’s Stock Yearly Top and Bottom Value

Coinbase’s stock is valued at $83.66 at 17:32 EST, way under its 52-week high of $368.90 and way above its 52-week low of $40.83.

Coinbase’s Moving Average

Coinbase’s value is way under its 50-day moving average of $107.90 and way under its 200-day moving average of $210.61.

Previous days news about Coinbase

  • Coinbase global (coin) earnings preview: wall street aims for 61% yoy revenue shortfall in Q2. According to FXStreet on Tuesday, 9 August, "Just last week BlackRock announced a partnership with Coinbase to give institutional clients access to crypto. ", "This quarter’s projections compared to adjusted EPS of $6.78 and revenue of $2.23 billion in the second quarter of 2021, so you can see just how vulnerable Coinbase is to gyrations in the crypto market. "

More news about Coinbase.

2. XP (XP) – -9.13%

XP Inc. is a technology-driven platform for financial services that offers financial products and services to Brazil. The company offers high-net-worth institutional customers as well as broker-dealer services. It also provides product structuring, capital markets and advisory services to mass-affluent clients. XP EducaASSAPSo is an online portal for financial education that provides classes and training to teach people about investing basics, investment techniques and strategies. It also operates XP Platform which is an open platform for clients that allows them to have access to investment products on the market. This includes equity and fixed-income securities, mutual funds and hedge funds as well as structured products. Life insurance, pension plans and real estate investment funds are just a few examples. It was established in 2001 in SAPSo Paulo in Brazil.

NASDAQ ended the session with XP falling 9.13% to $18.66 on Thursday while NASDAQ fell 0.58% to $12,779.91.

Volume

Today’s last reported volume for XP is 10508200 which is 151.74% above its average volume of 4174190.

XP’s last close was $20.53, 61.32% below its 52-week high of $53.08.

XP’s Sales

XP’s sales growth is 54.5% for the present quarter and 46.5% for the next. The company’s growth estimates for the current quarter and the next is 36.8% and 13%, respectively.

XP’s Revenue

Year-on-year quarterly revenue growth grew by 57.1%, now sitting on 10.14B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

XP’s stock is considered to be overbought (>=80).

XP’s Stock Yearly Top and Bottom Value

XP’s stock is valued at $18.66 at 17:32 EST, way below its 52-week low of $27.65.

XP’s Moving Average

XP’s worth is way under its 50-day moving average of $33.30 and way below its 200-day moving average of $40.20.

More news about XP.

3. Sorrento Therapeutics (SRNE) – -6.93%

Sorrento Therapeutics, Inc., is a biopharma company at clinical stage. It develops treatments for neurodegenerative, autoimmune, and cancer. The company operates in two segments: Sorrento Therapeutics, and Scilex. It offers cancer therapies by using its G-MAB proprietary antibody library and targeted delivery modes. These include CAR-T, dimeric antigen T-cell treatment (CAR-T), and antibody drug conjugates as well as bispecific approaches. Sofusa is a technology to deliver biologics directly into your lymphatic system. The company is also developing anti-CD38 CAR–T therapies for multiple myeloma and amyloidosis. It also develops resiniferatoxin (a non-opioid TRPV1 antagonist neurotoxin) for treatment of osteoarthritis and late-stage cancer; ZTlido (a lidocaine delivery method for postherpetic nerve pain); and ZTiro (a lidocaine delivery device for treatment of postherpetic narcolepsy). SEMDEXA is an injectable viscous jelly formulation that the company has been developing. It’s currently in Phase III clinical trials for sciatica. SP-103 is an investigational, non-aqueous, lidocaine-based topical system in chronic low-back pain. SmartPharm Therapeutics Inc. is one of its partners in developing a gene-encoded vaccine against COVID-19. Celularity, Inc. initiated Phase I/II clinical studies, which included up to 86 patients. Mount Sinai Health System was involved in the development of COVI-SHIELD, an anti-SARS treatment. It also has a preclinical agreement with Galveston’s University of Texas Medical Branch for testing Sorrento’s COVID-19 therapeutic products candidates. It was established in San Diego in 2006.

NASDAQ ended the session with Sorrento Therapeutics dropping 6.93% to $2.49 on Thursday, following the last session’s upward trend. NASDAQ fell 0.58% to $12,779.91, following the last session’s upward trend on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for Sorrento Therapeutics is 6511630 which is 36.83% below its average volume of 10309200.

Sorrento Therapeutics’s last close was $2.67, 72.27% under its 52-week high of $9.63.

Sorrento Therapeutics’s Sales

Sorrento Therapeutics’s sales growth is 29% for the present quarter and 85.1% for the next. The company’s growth estimates for the current quarter is a negative 1700% and positive 77.2% for the next.

Sorrento Therapeutics’s Revenue

Year-on-year quarterly revenue growth grew by 13.7%, now sitting on 52.9M for the twelve trailing months.

Sorrento Therapeutics’s Stock Yearly Top and Bottom Value

Sorrento Therapeutics’s stock is valued at $2.49 at 17:32 EST, way under its 52-week high of $9.63 and way above its 52-week low of $1.15.

Sorrento Therapeutics’s Moving Average

Sorrento Therapeutics’s worth is way higher than its 50-day moving average of $2.07 and way below its 200-day moving average of $3.49.

More news about Sorrento Therapeutics.

4. Revlon New (REV) – -6.79%

Through its subsidiaries, Revlon, Inc. develops, produces, markets, distributes, sells, and supports beauty and personal care products around the world. Relvon, the company’s color cosmetics segment, offers beauty products under Revlon brands. Revlon ColorSilk is the Revlon Professional brand for hair color. The Elizabeth Arden segment sells, markets and distributes skin care products for Elizabeth Arden Ceramide and Prevage brands. It also has fragrances that are under Elizabeth Arden White Tea and Elizabeth Arden Red Door brands. Its Portfolio segment includes color cosmetics from the SinfulColors and Almay brands, men’s grooming products for the American Crew brands, nail polishes and gel nails under CND, anti-perspirant products under Mitchum, hair care products under Creme of Nature, and a hair color range under Llongueras. The Fragrances segment markets and distributes licensed and owned fragrances as well as prestige brands that are owned or licensed by the company. The Juicy Couture and AllSaints brand names are available. The company’s products are sold through independent distributors and sales reps. It also licenses the Revlon and Red Door trademarks for complementary products and accessories to other beauty products. Revlon, Inc., was established in New York, New York, in 1932.

NYSE ended the session with Revlon New falling 6.79% to $6.73 on Thursday while NYSE jumped 0.32% to $15,602.93.

Volume

Today’s last reported volume for Revlon New is 1083240 which is 94.12% below its average volume of 18449200.

Revlon New’s last close was $7.22, 59.09% under its 52-week high of $17.65.

The company’s growth estimates for the current quarter is a negative 4.8% and positive 8.2% for the next.

Revlon New’s Revenue

Year-on-year quarterly revenue growth grew by 7.8%, now sitting on 2.11B for the twelve trailing months.

Revlon New’s Stock Yearly Top and Bottom Value

Revlon New’s stock is valued at $6.73 at 17:33 EST, way under its 52-week high of $17.65 and way higher than its 52-week low of $1.08.

Revlon New’s Moving Average

Revlon New’s worth is way above its 50-day moving average of $5.48 and way under its 200-day moving average of $8.42.

More news about Revlon New.

5. GlaxoSmithKline (GSK) – -6.67%

GlaxoSmithKline plc is involved in creating, developing, manufacturing, marketing, and selling pharmaceutical products and vaccines. It also markets health-related consumer goods in the United Kingdom and the United States. The company operates in four areas: Pharmaceuticals R&D and Vaccines. It offers pharmaceutical products that include medicines for the following therapeutic areas: respiratory, HIV/AIDS, immuno-inflammation and oncology. The company also offers consumer health products for wellness, nutrition, skin, and other categories. It offers a variety of consumer products including nasal sprays. Tablets, syrups. lozenges. Gum and transdermal patches. Caplets. Infant syrup drops. Liquid filled suspension. Wipes. Gels. Effervescents. Toothpastes. Denture adhesives. Cleansers. Topical creams. Non-medicated patches. Lip balms. Gummies. Soft chews. There are collaboration agreements with 23andMe, Merck KGaA, Lyell Immunopharma and Innovax University. VBI; Viome. Sanofi SA. CureVac. Sengenics is also involved in research. GlaxoSmithKline plc, which was established in 1715, is located in Brentford in the United Kingdom.

NYSE ended the session with GlaxoSmithKline sliding 6.67% to $35.74 on Thursday, after five sequential sessions in a row of losses. NYSE rose 0.32% to $15,602.93, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Volume

Today’s last reported volume for GlaxoSmithKline is 34326500 which is 511.63% above its average volume of 5612260.

GlaxoSmithKline’s last close was $38.30, 20.03% below its 52-week high of $47.89.

The company’s growth estimates for the ongoing quarter and the next is a negative 10.1% and a negative 17.8%, respectively.

GlaxoSmithKline’s Revenue

Year-on-year quarterly revenue growth grew by 31.8%, now sitting on 36.48B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

GlaxoSmithKline’s stock is considered to be overbought (>=80).

GlaxoSmithKline’s Stock Yearly Top and Bottom Value

GlaxoSmithKline’s stock is valued at $35.74 at 17:33 EST, way under its 52-week high of $47.89 and higher than its 52-week low of $32.96.

GlaxoSmithKline’s Moving Average

GlaxoSmithKline’s value is way below its 50-day moving average of $43.01 and way below its 200-day moving average of $43.83.

More news about GlaxoSmithKline.

6. Exact Sciences (EXAS) – -5.95%

Exact Sciences Corporation offers cancer screening and diagnostic products both in the United States as well internationally. Cologuard is a stool-based, non-invasive DNA screening test that detects colorectal and precancer. Oncotype DX is a test that detects advanced stages of prostate and breast cancers. Its current pipeline products focus on research and development to enhance Cologuard’s performance characteristics and blood- or fluid-based testing. The company has licensing agreements with Biocartis N.V., Mayo Foundation for Medical Education and Research, and Hologic, Inc. Exact Sciences Corporation was established in 1995. It is located in Madison, Wisconsin.

NASDAQ ended the session with Exact Sciences falling 5.95% to $42.44 on Thursday, following the last session’s upward trend. NASDAQ dropped 0.58% to $12,779.91, following the last session’s upward trend on what was a somewhat down trend exchanging session today.

Volume

Today’s last reported volume for Exact Sciences is 3328590 which is 57.97% above its average volume of 2106980.

Exact Sciences’s last close was $45.13, 58.59% below its 52-week high of $108.99.

Exact Sciences’s Sales

Exact Sciences’s sales growth is 10.8% for the current quarter and 7.7% for the next. The company’s growth estimates for the present quarter is a negative 11.3% and positive 16.4% for the next.

Exact Sciences’s Revenue

Year-on-year quarterly revenue growth grew by 21%, now sitting on 1.85B for the twelve trailing months.

Exact Sciences’s Stock Yearly Top and Bottom Value

Exact Sciences’s stock is valued at $42.44 at 17:33 EST, way below its 52-week high of $108.99 and way higher than its 52-week low of $35.34.

Exact Sciences’s Moving Average

Exact Sciences’s value is under its 50-day moving average of $44.98 and way under its 200-day moving average of $67.05.

More news about Exact Sciences.

7. HubSpot (HUBS) – -5.73%

HubSpot, Inc. offers a cloud-based platform that enables businesses to market, sell, and support customers in Europe, the Americas, Asia Pacific, and Europe. It offers integrated software applications such as search engine optimization and blogging, website content management, messaging and chatbots. The company also provides professional support via phone, email, and chat. This company serves middle-market businesses-to-business. HubSpot, Inc., was established in 2005. It is located in Cambridge, Massachusetts.

NYSE ended the session with HubSpot dropping 5.73% to $383.76 on Thursday while NYSE rose 0.32% to $15,602.93.

Volume

Today’s last reported volume for HubSpot is 731833 which is 5.4% below its average volume of 773667.

HubSpot’s last close was $407.07, 52.99% under its 52-week high of $866.00.

HubSpot’s Sales

HubSpot’s sales growth is 38.7% for the ongoing quarter and 30.3% for the next.

HubSpot’s Revenue

Year-on-year quarterly revenue growth grew by 46.5%, now sitting on 1.3B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

HubSpot’s stock is considered to be overbought (>=80).

HubSpot’s Stock Yearly Top and Bottom Value

HubSpot’s stock is valued at $383.76 at 17:33 EST, way below its 52-week high of $866.00 and way above its 52-week low of $257.21.

HubSpot’s Moving Average

HubSpot’s value is way above its 50-day moving average of $314.73 and way below its 200-day moving average of $507.85.

More news about HubSpot.

8. StoneCo (STNE) – -5.59%

StoneCo Ltd. offers financial technology solutions for clients and integrate partners. It allows customers to transact electronically in Brazil through in-store and online channels. StoneCo Ltd. distributes their solutions through its proprietary Stone Hubs. These hubs offer local sales and services, and technology and solutions for digital merchants via sales personnel, technical vendors and sales staff. It also sells brick-and mortar and digital merchants with the help of a sales team. As of December 31, 2019, the company served approximately 495,100 clients primarily small-and-medium-sized businesses; and 116 integrated partners, such as global payment service providers, digital marketplaces, and integrated software vendors. It was established in 2012 in George Town in the Cayman Islands.

NASDAQ ended the session with StoneCo sliding 5.59% to $11.27 on Thursday while NASDAQ fell 0.58% to $12,779.91.

Volume

Today’s last reported volume for StoneCo is 4349710 which is 47.62% below its average volume of 8304620.

StoneCo’s last close was $11.94, 80.18% below its 52-week high of $60.25.

The company’s growth estimates for the current quarter is a negative 66.7% and positive 187.5% for the next.

StoneCo’s Revenue

Year-on-year quarterly revenue growth grew by 207%, now sitting on 6.13B for the twelve trailing months.

StoneCo’s Stock Yearly Top and Bottom Value

StoneCo’s stock is valued at $11.27 at 17:33 EST, way below its 52-week high of $60.25 and way above its 52-week low of $6.81.

StoneCo’s Moving Average

StoneCo’s value is way higher than its 50-day moving average of $8.99 and way under its 200-day moving average of $15.27.

More news about StoneCo.

9. Upwork (UPWK) – -5.45%

Upwork Inc. is an online talent platform that allows businesses to connect with independent freelancers and agencies in America, India and the Philippines. Upwork Inc.’s platform allows access to approximately 8,000 talents in approximately 70 areas, such as content marketing, customer services, data science, analytics, graphic design and mobile development. It also offers sales and web development. The platform allows clients to automate their workflows such as contracting, talent sourcing and outreach. Its platform provides access to many functions for remote collaboration with freelancers, including communication and collaboration as well as time tracking and invoicing. The marketplace offers include Upwork Basic and Plus, Upwork Business and Enterprise, Upwork Payroll and managed and online escrow services. The business was previously known as ElanceoDesk, Inc., but it changed its name in May 2015 to Upwork Inc. Upwork Inc. was founded in 2013. It is located in Santa Clara California.

NASDAQ ended the session with Upwork falling 5.45% to $19.00 on Thursday while NASDAQ dropped 0.58% to $12,779.91.

Volume

Today’s last reported volume for Upwork is 1816750 which is 33.74% above its average volume of 1358420.

Upwork’s last close was $20.09, 67.54% under its 52-week high of $61.90.

Upwork’s Sales

Upwork’s sales growth is 24.4% for the current quarter and 20% for the next. The company’s growth estimates for the current quarter and the next is a negative 366.7% and a negative 200%, respectively.

Upwork’s Revenue

Year-on-year quarterly revenue growth grew by 24.4%, now sitting on 530.52M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Upwork’s stock is considered to be overbought (>=80).

Upwork’s Stock Yearly Top and Bottom Value

Upwork’s stock is valued at $19.00 at 17:33 EST, way below its 52-week high of $61.90 and way above its 52-week low of $14.85.

Upwork’s Moving Average

Upwork’s worth is below its 50-day moving average of $19.66 and way under its 200-day moving average of $28.96.

More news about Upwork.

10. MicroVision (MVIS) – -5.32%

MicroVision, Inc. creates PicoP scanning technology for high-resolution miniature projectors, three-dimensional sensing, and image capture in America and Asia. PicoP’s scanning technology is made up of micro-electrical mechanical and laser diodes as well opto-mechanics and electronics. It also produces a light detection engine and ranging engine that can be used in consumer electronics and automobile collision avoidance systems. The company licenses products to original equipment and design manufacturers. MicroVision, Inc., was established in 1993. It is located in Redmond, Washington.

NASDAQ ended the session with MicroVision sliding 5.32% to $5.34 on Thursday while NASDAQ dropped 0.58% to $12,779.91.

Volume

Today’s last reported volume for MicroVision is 3029820 which is 3.74% above its average volume of 2920360.

MicroVision’s last close was $5.64, 65.57% under its 52-week high of $16.38.

MicroVision’s Sales

MicroVision’s sales growth is 53.2% for the present quarter and 151.3% for the next. The company’s growth estimates for the present quarter and the next is a negative 50% and a negative 12.5%, respectively.

MicroVision’s Revenue

Year-on-year quarterly revenue growth declined by 57.9%, now sitting on 1.94M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

MicroVision’s stock is considered to be oversold (<=20).

MicroVision’s Stock Yearly Top and Bottom Value

MicroVision’s stock is valued at $5.34 at 17:33 EST, way below its 52-week high of $16.38 and way higher than its 52-week low of $2.50.

MicroVision’s Moving Average

MicroVision’s worth is way above its 50-day moving average of $4.34 and way above its 200-day moving average of $4.85.

More news about MicroVision.

Stay up to date with our winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here